Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Provectus Biopharmaceuticals, Inc. (PVCT) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Provectus Biopharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 315545.
Total stock buying since 2014: $10,800.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $841,686.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2017 | 200,000 | $10,800 | 0 | $0 | 0 | $0 |
| 2015 | 0 | $0 | 0 | $0 | 590,098 | $550,065 |
| 2014 | 0 | $0 | 0 | $0 | 348,236 | $291,621 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2017-12 | 200,000 | $10,800 | 0 | $0 | 0 | $0 |
| 2015-12 | 0 | $0 | 0 | $0 | 265,214 | $258,901 |
| 2015-01 | 0 | $0 | 0 | $0 | 324,884 | $291,164 |
| 2014-12 | 0 | $0 | 0 | $0 | 126,361 | $80,871 |
| 2014-10 | 0 | $0 | 0 | $0 | 96,875 | $62,000 |
| 2014-06 | 0 | $0 | 0 | $0 | 100,000 | $125,000 |
| 2014-05 | 0 | $0 | 0 | $0 | 25,000 | $23,750 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-12-14 | Glass John R (See Remarks) | Buy | 200,000 | .05 | 10,800 |
| 2015-12-21 | Wachter Eric Phd (Chief Technology Officer) | Option Ex | 120,000 | 1.02 | 122,400 |
| 2015-12-09 | Culpepper Peter R (CFO & COO) | Option Ex | 145,214 | .94 | 136,501 |
| 2015-01-24 | Wachter Eric Phd (Chief Technology Officer) | Option Ex | 185,000 | 1.02 | 188,700 |
| 2015-01-07 | Culpepper Peter R (CFO & COO) | Option Ex | 63,120 | .84 | 53,336 |
| 2015-01-07 | Scott Timothy Phd (President) | Option Ex | 76,764 | .64 | 49,128 |
| 2014-12-30 | Scott Timothy Phd (President) | Option Ex | 126,361 | .64 | 80,871 |
| 2014-10-29 | Scott Timothy Phd (President) | Option Ex | 96,875 | .64 | 62,000 |
| 2014-06-28 | Culpepper Peter R (CFO & COO) | Option Ex | 100,000 | 1.25 | 125,000 |
| 2014-05-19 | Scott Timothy Phd (President) | Option Ex | 25,000 | .95 | 23,750 |
Insider trading activities including stock purchases, stock sales, and option exercises of PVCT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Provectus Biopharmaceuticals, Inc. (symbol PVCT, CIK number 315545) see the Securities and Exchange Commission (SEC) website.